Intellipharmaceutics International Inc T.IPCI

Primary Symbol: V.IPCI.H Alternate Symbol(s): IPCIF

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. It also provides analytical services.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > Buyer beware!

<< Previous

Bullboard Posts

Next >>

Comment by biggerron Apr 25, 2021 7:25pm

308 Views

Post# 33064380

RE:Buyer beware!

They've been saying since last November that if they get enough money they'll be launching generic Seroquel XR®, generic Pristiq® and generic Effexor XR® and now with the PP they could have the money. These brand names were big money makers and this will inrease the revenue significantly IMHO, right now revenue is zero

<< Previous

Bullboard Posts

Next >>

This company starts production at what could be Canada’s next great gold mine